|
What’s Inside: Meet the 2024 Catalyst Awards Winners; Gray Matter by Graymark Capital Completes Westlake Labs; Our Full Report on the Election Results; and more.
|
We’re championing the progress made by California’s life science community and want to hear about your company’s latest scientific breakthrough, investment milestone, or commitment to creating positive change for our industry. Submit your story here for possible inclusion in an upcoming issue. |
|
|
What’s Happening at Biocom California
|
|
|
|
Biocom California Appoints New Members to its Board of Governors
Last week, Biocom California announced three new appointments to its board of governors. Kathryn Lowell, group vice president of global government affairs at BioMarin; Stephen Hatke, vice president of operations and site head for Takeda; and Tina Self, senior vice president, biologics manufacturing capacity cluster leader and Berkeley site head at Bayer.
“With deep knowledge of the healthcare industry, government policy and pharmaceutical manufacturing, Ms. Lowell, Mr. Hatke and Ms. Self offer invaluable insights that will ultimately foster and continue driving innovation across the state,” said Joe Panetta, president and CEO of Biocom California.
|
Meet Our 2024 Catalyst Awards Winners
Tonight we will recognize the most inspiring and driven minds who are sparking meaningful change to human health through research, discovery and entrepreneurship—all before their 40th birthdays—at our Annual Gala. This year’s Catalyst Awards winners are a group of ten individuals who are igniting innovation in California’s vibrant life science community. Join us in congratulating these up-and-coming leaders. Life science industry professionals and supporters from across the state will gather at the Hyatt Regency La Jolla, where the evening will be highlighted by a tribute to our outgoing president and CEO, Joe Panetta.
|
|
|
Industry Intelligence & Member Moments
|
- 23andMe and Mirador Therapeutics announced a collaboration to leverage genetic data and Mirador360 for precision medicine in immunology and inflammation.
- Alamar Biosciences partnered with The Michael J. Fox Foundation to advance biomarker discovery and deepen understanding of Parkinson’s disease.
- Gray Matter by Graymark Capital completed Westlake Labs, a 99,000-square-foot Class A life science building in Westlake Village featuring 35,000 square feet of modular lab space with Conejo Valley views.
- Grenova appointed Katherine Marrs as its new CEO, succeeding Lane Major, who will remain involved with the company as a Board member.
- Kenai Therapeutics formed a Patient Advisory Board to incorporate patient insights as it advances its lead Parkinson’s candidate to the clinic.
- Maravai LifeSciences announced an agreement to acquire Officinae Bio’s DNA and RNA business, enhancing support for nucleic acid-based therapies.
- MyoGene Bio was granted Orphan Drug Designation and Rare Pediatric Disease Designation for their gene editing therapy for Duchenne muscular dystrophy.
- The Parker Institute for Cancer Immunotherapy unveiled its inaugural 2024 Representation in SciencE Scholars, committing $525,000 to support their research.
- Rapid Product Creations, specializing in prototypes and low-volume components, marked its three-year anniversary with an interview featuring founder Colin Rawson.
- Salk professors Joseph Ecker, Ronald Evans, Rusty Gage, Satchidananda Panda, Reuben Shaw and Kay Tye, as well as research assistant Joseph Nery, have all been named to the Highly Cited Researchers list by Clarivate.
- Sangamo Therapeutics received FDA clearance of its IND for ST-503, an epigenetic therapy for chronic pain caused by idiopathic small fiber neuropathy.
- Takara Bio USA launched its SmartChip ND Real-Time PCR System, an automated, research-use-only, high-throughput qPCR solution for infectious disease research.
- UC San Diego researchers have developed a new and improved wearable ultrasound patch for continuous and noninvasive blood pressure monitoring.
|
|
California and D.C. Election Results: New Faces and Key Changes
A central theme of the 2024 general election is “change.” Former President Donald Trump is returning to the White House, Congressman Adam Schiff will become California’s junior senator, and a Republican incumbent lost re-election in the House of Representatives, with two races still uncalled. These shifts could significantly impact House leadership, as future vacancies may challenge the Republican’s ability to sustain its narrow majority. In the State Legislature, Democrats held their overwhelming supermajorities in both houses. A former life science researcher, Dr. Darshana Patel, was victorious in the 76th Assembly District. The new State Legislature will have at least 30 new members, a stunning 25 percent turnover in one year. In local races, all San Diego incumbents were victorious; Daniel Lurie will be San Francisco’s next mayor; and two new city councilmembers will be seated in Los Angeles. We will keep you abreast of what all of this means for our life science industry as more unfolds. Read our full report on election results.
|
|
Biocom California
For over 29 years, Biocom California has helped move the life science industry forward with transformative resources that enable companies to make meaningful connections. With a membership base of over {{{dynamic_content_1600}}} companies, we connect our members to each other so they can collaborate and work stronger and smarter together. We connect organizations to capital investment and purchasing solutions so they can grow faster and work more efficiently. We’re their link to advocacy that fights for innovation and we provide an environment where their business and talent can thrive. Biocom California is how the life science industry gets connected.
|
|
|
